|
Body-Weight Trajectory
|
G07.345.249.314.120.200.463 |
|
|
Body Weight Changes
|
G07.345.249.314.120.200 |
|
|
1-Alkyl-2-acetylglycerophosphocholine Esterase
|
D08.811.277.352.100.680.750.937.249 |
|
|
Catheterization, Central Venous
|
E04.100.814.529.875 |
|
|
Polycarboxylate Cement
|
D25.339.291.700 |
|
|
Public Health
|
N01.400.550 |
|
|
Smallpox Vaccine
|
D20.215.894.899.859 |
|
|
Cytokine-Induced Killer Cells
|
A15.382.490.555.283 |
|
|
Sumoylation
|
G02.111.660.871.790.600.925.500 |
|
|
Ubiquitination
|
G02.111.660.871.790.600.925 |
|
|
Enkephalin, Leucine-2-Alanine
|
D12.644.400.575.281.231.500 |
|
|
Enkephalin, Leucine
|
D12.644.400.575.281.231 |
|
|
Pseudomonas chlororaphis
|
B03.440.400.425.625.625.223 |
|
|
Microgels
|
D25.720.501 |
|
|
Thiazepines
|
D02.886.680.702 |
|
|
Spirostans
|
D04.210.500.247.515 |
|
|
Topoisomerase II Inhibitors
|
D27.505.954.248.794.750 |
|
|
Topoisomerase Inhibitors
|
D27.505.954.248.794 |
|
|
Peritoneal Dialysis, Continuous Ambulatory
|
N02.421.585.106.500 |
|
|
Ambulatory Care
|
N02.421.585.106 |
|
